# Proposed Improvements

The workflow components presented in this repository originated from the identification of practical limitations encountered during routine rare disease genomic analyses.

Rather than representing a fully implemented clinical pipeline, this repository documents a series of workflow optimization proposals designed to improve analytical performance, reproducibility, and diagnostic interpretability across key stages of rare disease genomics.

The proposed improvements focus on three areas where methodological choices can substantially influence diagnostic outcomes.

---

## Structural Variant Analysis

### Problem Addressed

Structural variant detection remains one of the most challenging areas of clinical genomics. Different SV callers often identify partially overlapping sets of variants due to differences in underlying methodologies, resulting in variability in sensitivity, breakpoint resolution, and detection of complex rearrangements.

Relying on a single caller may therefore reduce the likelihood of identifying clinically relevant structural alterations.

### Proposed Improvement

The integration of complementary SV callers such as Manta and LUMPY was proposed to:

* Benchmark complementary SV callers to improve sensitivity for deletions, duplications, inversions, and complex rearrangements.
* Improve breakpoint resolution through the combined use of split-read and paired-end evidence.
* Standardize output formats to facilitate downstream comparison, integration, and reproducibility.
* Support systematic evaluation of concordance and caller-specific findings.

### Expected Impact

Combining complementary SV detection approaches may improve the identification of clinically relevant structural alterations while increasing confidence in breakpoint characterization and downstream variant interpretation.

---

## Mitochondrial DNA Analysis

### Problem Addressed

Mitochondrial DNA analysis is not systematically incorporated into many routine genomics workflows despite its relevance in rare disease diagnostics. Consequently, pathogenic mtDNA deletions, rearrangements, or heteroplasmy patterns may remain undetected during standard analyses.

### Proposed Improvement

The integration of eKLIPse was proposed to:

* Incorporate mtDNA structural analysis into the routine genomic workflow.
* Quantify mtDNA rearrangements and heteroplasmy levels to support clinical interpretation.
* Standardize and document mtDNA analytical procedures.
* Improve workflow transparency and traceability for mitochondrial analyses.

### Expected Impact

The inclusion of dedicated mtDNA analyses could expand diagnostic coverage and facilitate the identification of pathogenic mitochondrial alterations that may not be detected through conventional nuclear genome pipelines.

---

## Variant Prioritization

### Problem Addressed

Variant prioritization is often one of the most time-consuming stages of rare disease diagnostics. Different prioritization tools rely on distinct methodologies and data sources, frequently producing different candidate rankings and creating challenges for reproducibility, consistency, and clinical interpretation.

### Proposed Improvement

The comparative evaluation of Exomiser, LIRICAL, and AMELIE was proposed to:

* Evaluate complementary prioritization strategies based on phenotype-genotype relationships and literature evidence.
* Assess ranking consistency across different tools and configurations.
* Optimize prioritization and filtering configurations to reduce manual interpretation burden while maintaining recovery of clinically relevant variants.
* Reduce the risk of excluding clinically relevant candidates through overly restrictive filtering strategies.
* Improve the interpretability and reproducibility of prioritization results.

### Expected Impact

Systematic comparison of prioritization strategies may help identify configurations that improve ranking consistency, reduce manual review burden, and increase confidence in candidate variant selection.

---

## Workflow Design Improvements

### Problem Addressed

Clinical bioinformatics workflows often evolve incrementally over time, which can lead to reduced reproducibility, limited scalability, and difficulties in benchmarking alternative analytical strategies.

### Workflow Design Improvements

The workflow architecture proposed in this repository aims to:

* Modularize analytical components to facilitate independent benchmarking and tool replacement.
* Maintain clear separation between configuration files, scripts, documentation, and results.
* Provide reproducible examples and technical documentation.
* Facilitate future workflow extension and adaptation to new analytical requirements.

### Expected Impact

A modular and well-documented workflow architecture can improve reproducibility, maintainability, transparency, and long-term scalability while supporting systematic evaluation of alternative analytical approaches.

---

## Summary of Proposed Improvements

| Area                        | Challenge                                                      | Proposed Improvement                          | Expected Benefit                                            |
| --------------------------- | -------------------------------------------------------------- | --------------------------------------------- | ----------------------------------------------------------- |
| Structural Variant Analysis | Variable sensitivity and breakpoint resolution across callers  | Integration of Manta and LUMPY                | Improved SV detection and breakpoint characterization       |
| mtDNA Analysis              | Lack of dedicated mitochondrial analysis in standard workflows | Integration of eKLIPse                        | Improved detection of mtDNA rearrangements and heteroplasmy |
| Variant Prioritization      | Variable ranking behavior across prioritization tools          | Benchmarking of Exomiser, LIRICAL, and AMELIE | More robust and reproducible candidate prioritization       |
| Workflow Design             | Limited reproducibility and scalability                        | Modular workflow architecture                 | Improved transparency, maintainability, and extensibility   |

---

Overall, these proposed improvements aim to support the development of more reproducible, scalable, and clinically meaningful workflows for rare disease genomics. Although some modules are presented as methodological proposals rather than validated clinical implementations, they illustrate practical strategies for improving diagnostic workflows and evaluating analytical alternatives in clinical genomics environments.
